Senslib Tablet

Adult dosage

Take 1 tablet daily for 21 days as indicated, followed by a 7-day break. It is preferable to take the medication at the same time each day. When starting for the first time, begin taking from the first day of menstruation, but should start by the 5th day of menstruation at the latest. For the first 7 days after starting, use an additional non-hormonal contraceptive method. When switching from another combination oral contraceptive, begin taking this medication the day after the last tablet of the previous contraceptive (no break period). However, if the previous contraceptive included a break period or inert tablets, start this medication the day after the break period ends or after the last inert tablet.

This medication is an oral contraceptive and may increase the risk of cardiovascular side effects. Women over 35 years old or those who smoke 15 or more cigarettes per day are at a higher risk of serious issues such as thrombosis and should avoid smoking while taking this medication. This medication should not be administered to individuals with estrogen-dependent tumors, thromboembolic disorders, cardiovascular diseases, severe hypertension, liver dysfunction, pregnant women, or nursing mothers. Additionally, it should not be taken by individuals allergic to its components or those with certain genetic metabolic disorders. Before taking this medication, medical and family histories must be checked, and regular examinations of blood pressure, breasts, and uterus should be conducted. If there is a family history of thrombosis, additional testing may be necessary. While taking this medication, various side effects such as headaches, depression, skin rashes, visual disturbances, dyspepsia, and changes in weight may occur. If any unusual symptoms arise, consult a doctor immediately. Furthermore, this medication can interact with other drugs, and the contraceptive effect may decrease when taken with antibiotics, antiepileptics, or certain antiviral drugs. It is essential to inform healthcare providers of any medications being taken. Pregnant or nursing women should not take this medication and should discontinue use immediately if pregnancy is confirmed. In case of overdose, symptoms like nausea, vomiting, dizziness, or breakthrough bleeding may occur, so caution is required. Store this medication out of reach of children.

Serious side effects

Venous thromboembolism, thrombosis, arterial thromboembolism, stroke, intracranial hemorrhage, cerebral thrombosis, myocardial infarction, pulmonary embolism, increased blood pressure, exacerbation of varicose veins, transient ischemic attacks, hemolytic uremic syndrome, cholestatic jaundice, malignant and benign liver tumors, hepatocellular tumors, optic neuritis, retinal thrombosis, anaphylaxis (including urticaria, angioedema, respiratory, and circulatory symptoms), migraines (including aura), sudden and severe headache,

Mild side effects

• Intermenstrual bleeding
• changes in menstrual flow and amenorrhea
• changes in vaginal discharge
• increase in size of uterine fibroids
• cervical erosion
• vaginal candidiasis
• vaginitis
• premenstrual syndrome
• dysmenorrhea
• breast tenderness and enlargement

Drug interactions

Do not take this medication with direct-acting antiviral agents for hepatitis C, phenytoin, barbiturates, primidone, carbamazepine, rifampicin, loperamide, aprepitant, bosentan, efavirenz, oxcarbazepine, topiramate, felbamate, griseofulvin, and St. John's wort, as well as cholesterol-lowering medications and antibiotics.

Food interactions

Do not take this medication with grapefruit juice.

This medication should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication and prevent degradation.

Appearance

White round sugar-coated tablet

Package unit

21 tablets/PTP